Your Article Summary
See Latest ArticlesDoripenem: position in clinical practice
Expert Review of Anti-infective Therapy, 06/08/09
Dedhia HV et al. - Doripenem is a novel carbapenem with a broad spectrum of activity against Gram-positive pathogens, anerobes and Gram-negative bacteria, including Pseudomonas aeruginosa. Doripenem is approved for the treatment of complicated intra-abdominal infection and urinary tract infections. It has been successfully used in the treatment of nosocomial and ventilator-associated pneumonia. It has a potential to be the drug of choice for these conditions. This evaluation focuses on the general review of the drug, including mechanisms of resistance, clinical efficacy and the position of doripenem in clinical practice.
Related Articles
Meta-analysis of doripenem vs comparators in patients with pseudomonas infections enrolled in four phase III efficacy and safety clinical trials
Current Medical Research and Opinion, 10/27/09
Relevance Score: 87%
Economic evaluation of doripenem for the treatment of nosocomial pneumonia in the US: discrete event simulation
Current Medical Research and Opinion, 11/13/09
Relevance Score: 84%
In Vivo Efficacy of 1- and 2-Gram Human Simulated Prolonged Infusions of Doripenem against Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, 10/08/09
Relevance Score: 80%
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients
Transplant Infectious Disease, 12/11/09
Voriconazole Pharmacokinetics and Pharmacodynamics in Children
Clinical Infectious Diseases, 12/11/09
Sequential treatment of cytomegalovirus infection or disease with a short course of intravenous ganciclovir followed by oral valganciclovir: efficacy, safety, and pharmacokinetics
Transplant Infectious Disease, 12/11/09
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnosis and treatment of spontaneous group A streptococcal peritonitis
British Journal of Surgery, 12/11/09
Using antimicrobial solution for irrigation in appendicitis to lower surgical site infection rates
The American Journal of Surgery, 12/11/09
Helicobacter species in the human colon
Colorectal Disease, 12/11/09
Today in Nosocomial Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetics and lung delivery of PDDS-aerosolized amikacin (NKTR-061) in intubated and mechanically ventilated patients with nosocomial pneumonia
Critical Care, 12/11/09
Occurrence of bloodstream infection with different types of central vascular catheter in critically neonates
Journal of Infection, 12/10/09
Imipenem-resistant Pseudomonas aeruginosa gastrointestinal carriage among hospitalized patients: risk factors and resistance mechanisms
Diagnostic Microbiology and Infectious Disease, 12/09/09
Today in Pulm/Thoracic Infections...keeping you current
Receive free subspecialty "5-minute updates" via email
Transmission of Pandemic H1N1 Influenza Virus and Impact of Prior Exposure to Seasonal Strains or Interferon Treatment
Journal of Virology, 12/11/09
Why mortality is increased in Healthcare-associated Pneumonia: lessons from pneumococcal bacteremic pneumonia
Chest, 12/11/09
Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease
European Respiratory Journal , 12/11/09
Today in Urogenital...keeping you current
Receive free subspecialty "5-minute updates" via email
Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients
Transplant Infectious Disease, 12/11/09
Prospective cohort study of acute pyelonephritis in adults: Safety of triage towards home based oral antimicrobial treatment
Journal of Infection, 12/10/09
Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea
Journal of Infection, 12/10/09